Carillon Tower Advisers’s West Pharmaceutical WST Stock Holding History

Carillon Tower Advisers’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$57.3M	Buy	+202,153	New	+$56.7M	0.35%	93
2020 Q3	–	Sell	-202,153	Closed	-$45.9M	–	494
2020 Q2	$45.9M	Buy	+202,153	New	+$39.7M	0.35%	93
2019 Q3	–	Sell	-235,498	Closed	-$29.5M	–	511
2019 Q2	$29.5M	Hold	235,498	–	–	0.2%	182
2019 Q1	$26M	Hold	235,498	–	–	0.18%	203
2018 Q4	$23.1M	Hold	235,498	–	–	0.2%	199
2018 Q3	$29.1M	Hold	235,498	–	–	0.21%	179
2018 Q2	$23.4M	Sell	235,498 -36,981	-14%	-$3.4M	0.18%	192
2018 Q1	$23.2M	Sell	272,479 -123,143	-31%	-$11.5M	0.18%	192
2017 Q4	$39K	Buy	+395,622	New	+$38.8M	0.42%	81

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Carillon Tower Advisers's WST Position: Q4 2020 in Review

Carillon Tower Advisers opened a new position in West Pharmaceutical (WST) in Q4 2020: 202,153 shares worth $57.3M. The stake represents 0.35% of the portfolio and ranks #93 among its holdings. This is a return to the name: Carillon Tower Advisers previously reported a position in WST as recently as Q2 2020.

Carillon Tower Advisers first reported a position in WST in Q4 2017 and has held it in 9 quarters since. 592 funds tracked by Wall St. Rank hold WST as of Q4 2020.

Carillon Tower Advisers held 202,153 shares of West Pharmaceutical worth $57.3M as of Q4 2020.
West Pharmaceutical was a new Carillon Tower Advisers position in Q4 2020.
West Pharmaceutical made up 0.35% of Carillon Tower Advisers's portfolio in Q4 2020, its #93 holding.
Carillon Tower Advisers first reported a position in West Pharmaceutical in Q4 2017 and has held it in 9 quarters since.
592 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.